Lupin Limited has informed the Exchange regarding a press release dated February 08, 2022, titled "Lupin Receives Approval from U.S. FDA for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 ml. ".
Lupin Limited has informed the Exchange regarding a press release dated February 08, 2022, titled "Lupin Receives Approval from U.S. FDA for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 ml. ".